- Home
- TLPH vs MKTW Comparison
TLPH vs MKTW Comparison
Compare TLPH & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLPH | MKTW |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 34.1M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TLPH | MKTW |
|---|---|---|
| Price | $0.92 | $13.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 227.4K | 9.8K |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | N/A | ★ 260.00 |
| EPS | N/A | ★ 1.54 |
| Revenue | $2,151,000.00 | ★ $512,403,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.48 |
| 52 Week High | $1.57 | $21.74 |
Technical Indicators
Market Signals| Indicator | TLPH | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 34.59 |
| Support Level | $0.86 | $12.65 |
| Resistance Level | $1.05 | $17.39 |
| Average True Range (ATR) | 0.06 | 0.61 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 62.43 | 0.00 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.